2015 American Transplant Congress » Poster Session C: Liver Donation and Allocation

Date: Monday, May 4, 2015

Time: 5:30pm-6:30pm

Location: Exhibit Hall E

Session Type: Poster Session

Meeting: 2015 American Transplant Congress

5:30pm-6:30pm: Comparison of Liver Transplant Outcomes for Recipients With MELD <35 Vs. >35

V. Kirchner, S. Chinnakotla, R. Kandaswamy, W. Payne, T. Pruett.

5:30pm-6:30pm: Consideration of the Futility of Transplant: 50% Mortality at 5 Years

S. Asrani, G. Saracino, J. O'Leary, G. Klintmalm, J. Trotter.

5:30pm-6:30pm: Descriptive Analysis of Patients Who Travel Away from Home for Orthotopic Liver Transplantation

C. Frenette,¹ A. Harper,³ J. Waalen,² J. Fisher,¹ R. Schaffer,¹ A. Baquerizo,¹ C. Marsh.¹

5:30pm-6:30pm: Distal Splenorenal Shunt (DSRS): A Durable Bridge to Liver Transplantation

J. Pomposelli, A. Tongyoo, R. Jenkins, M. Akoad, W. Lewis, E. Pomfret.

5:30pm-6:30pm: Does BMI Affect Survival in Cadaveric Liver Transplantation for Benign Conditions?

S. Ayloo, S. Hurton, M. Cwinn, R. Kavanagh, M. Molinari.

5:30pm-6:30pm: Donor Hemodynamic Profile Presages Graft Survival in Donation After Cardiac Death Liver Transplantation

M. Ertreo, C. Desai, R. Girlanda, T. Frias, T. Fishbein.

5:30pm-6:30pm: Evaluation of the Effects of N-Acetylcysteine Treatment in Adult Liver Transplant Recipients

E. Aldag, S. Farrell, R. Pedersen, A. Sahajpal, J. Clendenon, V. Gunabushanam, D. Kramer.

5:30pm-6:30pm: Grip Strength, Gait Speed, and Chair Stands Predict Sarcopenia in Male But Not Female Liver Transplant Candidates

C. Wang, S. Feng, K. Covinsky, H. Hayssen, B. Yeh, J. Lai.

5:30pm-6:30pm: HLA Matching Affects Patient Survival, Graft Survival, and Incidence of Rejection Episodes in Largest Analysis to Date

J. Weiner, Z. Cui, S. Mohan, E. Verna, A. Griesemer, J. Emond.

5:30pm-6:30pm: Historical Comparison of Projected and Observed Liver Transplants

J. Pyke,¹ D. Schladt,¹ W. Kim,⁵ S. Leppke,¹ J. Lake,⁴ S. Gentry,^2,3 D. Segev,² A. Israni,¹ J. Snyder.¹

5:30pm-6:30pm: Impact of Donor Post-Extubation O2 Delivery on Recipient Hypoxic Cholangiopathy in Donation After Circulatory Death Liver Transplantation: The University of Colorado Experience

T. Chirichella,¹ C. Dunham,² M. Zimmerman,⁴ K. Conzen,¹ S. Kelley,³ E. Phelan,¹ T. Steinberg,¹ T. Nydam,¹ T. Bak,¹ I. Kam,¹ M. Wachs.¹

5:30pm-6:30pm: In House Oxygen Persufflation of Cold Stored Livers Versus Simple Cold Storage in Extended Criteria Liver Grafts: Results of a Randomized Controlled Clinical Trial

A. Gallinat,¹ A. Paul,¹ D. Hoyer,¹ C. Klein,¹ S. Swoboda,¹ C. Ose,² Z. Mathe,¹ J. Treckmann,¹ T. Minor.³

5:30pm-6:30pm: Induction Therapy With either Anti-Thymocyte Antibodies or Il2 Receptor Inhibitors Appears to Decrease the Risk of Graft Loss in DCD Liver Transplantation Compared to No Induction Therapy

S. Rayhill, J. Haldorson, A. Dick, S. Nazarian, L. Sibulesky, M. Montenovo, L. Yu, I. Javid, T. Pearson, R. Bakthavatsalam, P. Healey, J. Perkins, J. Reyes.

5:30pm-6:30pm: Liver Transplantation in Children Using Organ Donation After Circulatory Death– An Analysis of the National Registry

G. El-Gazzaz, K. Hashimoto, M. Fujiki, T. Daigo, C. Quintino, F. Aucejo, D. Kelly, C. Winans, C. Miller, J. Fung, B. Eghtesad.

5:30pm-6:30pm: MELD as a Predictor of Post-Transplant Survival

X. Luo, A. Massie, A. Poon, D. Segev.

5:30pm-6:30pm: National Outcomes of Donation After Cardiac Death (DCD) Liver Transplantation Are Equivalent to Donation After Brain Death (DBD) Liver Transplantation Using Older (DBD) Donor Livers

R. Redfield, M. Rizzari, J. Scalea, L. Fernandez, A. D'Alessandro, J. Mezrich, D. Foley.

5:30pm-6:30pm: Nonalcoholic Steatohepatitis as Indication for Liver Transplantation in Europe. Do We Choose the Right Organs for the Right Recipients?

B. Kern,¹ P. Newsome,² V. Karam,³ R. Adam,³ G. Berlakovich,⁴ J. Fritz,⁵ W. Popp,¹ B. Feurstein,¹ A. Pascher,⁶ P. Muiesan,⁷ S. Schneeberger.¹

5:30pm-6:30pm: Outcomes of Living and Deceased Donor Liver Transplant Recipients According to the MELD Score

J. Lee, J. Lee, D. Joo, D. Han, M. Ju, J. Choi, S. Kim, M. Kim.

5:30pm-6:30pm: Racial Disparities in Living Donor Liver Transplantation

Y. Nobel,¹ K. Forde,² L. Wood,³ P. Yoo,⁴ P. Abt,³ D. Goldberg.²

5:30pm-6:30pm: Sex Differences in Mortality Rate Among Patients Waiting for Liver Transplantation

Z. Cui,^1,2 X. Luo,² A. Massie,² D. Segev.²

5:30pm-6:30pm: Single-Center Analysis of Adult, Combined Heart-Liver Transplant (CHLT) Recipients

H. Monsour Jr,¹ M. Boktour,² A. Abimbola,¹ M. Elnemr,¹ S. Gordon Burroughs,² D. Victor III,¹ A. Saharia,² B. Trachtenberg,³ A. Bhimaraj,³ A. Gaber,² J. Estep,³ R. Ghobrial.²

5:30pm-6:30pm: The Donor Risk Index Does Not Accurately Classify Patients With or Without Graft Failure

E. Franco,¹ T. Athanasios,² N. Kemmer,³ L. Leone,¹ A. Alsina,¹ B. Djulbegovic.²

5:30pm-6:30pm: The Impact of CDC High Risk Donors on Patient and Graft Survival After Liver Transplantation

D. Moonka, A. Yoshida, A. Taylor.

5:30pm-6:30pm: The Impact of Ischemia/Reperfusion Injury On Liver Allografts from Deceased After Cardiac Death Versus Deceased After Brain Death Donors

B. Sayed, J. Xu, A. Casas-Ferreira, P. Srinivasan, N. Heaton, Y. Ma, C. Legido-Quigley, S. Fuggle, W. Jassem.

5:30pm-6:30pm: U.S. National Experience of Liver Transplantation Using Allografts from Octogenarian Donors

C. Bhati, I. Tzvetanov, R. Garcia-Roca, J. Oberholzer, E. Benedetti, H. Jeon.

5:30pm-6:30pm: Use of MELD Exception Points in Patients With Hepatic Neuroendocrine Tumor Metastases: Variable Use and Proposed Criterion for Approval

Y. Nobel,¹ D. Goldberg.^2,3,4

5:30pm-6:30pm: Utilization and Characteristics of Liver Donors in the US by OPTN-Defined Increased Risk Donor Status

M. Ison,^1,2 M. Abecassis,² D. Ladner.²

5:30pm-6:30pm: Utilization of Liver Allografts from Deceased Donors. Non Medical Causes for Discard. A Review of the SRTR Annual Report

M. Asolati,¹ C. Kulig,² B. Bilir,² T. Pillen,¹ P. Gauthier,² B. Bista,² T. Heffron.¹

5:30pm-6:30pm: Utilizing CDC High Risk Donors to Improve Outcomes in Liver Transplantation

V. Fleetwood, J. Lusciks, M. Hertl, E. Chan.

5:30pm-6:30pm: Validation of the Early Postoperative labMELD as Predictor of Outcome After Transplantation of Extended Criteria Donor Livers

D. Hoyer,¹ A. Gallinat,¹ T. Minor,² F. Saner,¹ P. Kocabayoglu,¹ J. Treckmann,¹ A. Paul.¹

« View all sessions from the 2015 American Transplant Congress